Lisata TherapeuticsLSTA
13F holders, Q1 2025 (March 31)22holders +1
3new positions
2sold out
1famous investor
$2.35avg. 13F price*
At the end of Q1 2025, 22 institutions reported holding Lisata Therapeutics Inc. (LSTA) in their 13F filings, up 1 from Q4 2024. 3 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($597K), BML Capital Management, LLC ($510K) and Renaissance Technologies ($241K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lisata Therapeutics Inc.
- CUSIP
- 128058302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $24K |
| Exits | 2 | $69K |
All 13F filers, Q4 2024 → Q1 2025: 90,278 shares bought and 92,652 shares sold, net −2,374 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Vanguard Group Inc. | 0.00% | Add +36.4% | 254,182 | $597K |
| BML Capital Management, LLC | 0.41% | Reduce -23.8% | 216,853 | $510K |
| Renaissance Technologies | 0.00% | Add +1.4% | 102,722 | $241K |
| Geode Capital Management, LLC | 0.00% | Add +8.3% | 60,529 | $142K |
| BlackRock, Inc. | 0.00% | Reduce -2.1% | 54,857 | $129K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -0.0% | 25,222 | $59K |
| State Street Corp. | 0.00% | No change | 14,348 | $34K |
| Cook Wealth, LLC | 0.01% | No change | 12,175 | $29K |
| Bank of America Corp. | 0.00% | Add +0.0% | 10,413 | $24K |
| Northern Trust Corp. | 0.00% | New | 10,268 | $24K |
| HighTower Advisors, LLC | 0.00% | No change | 10,042 | $24K |
| Royal Bank of Canada | 0.00% | Add +11269.2% | 5,912 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +15.3% | 2,207 | $5K |
| Founders Capital Management | 0.00% | No change | 2,000 | $5K |
| Morgan Stanley | 0.00% | No change | 1,466 | $3K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -74.1% | 140 | $329 |
| JPMorgan Chase & Co. | 0.00% | Reduce -13.3% | 13 | $31 |
| Barclays PLC | 0.00% | No change | 4 | $9 |
| Cheviot Value Management, LLC | 0.00% | New | 3 | $7 |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0.00% | New | 2 | $5 |
| Wells Fargo & Company | 0.00% | No change | 1 | $2 |
| UBS Group AG | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is LSTA's weight in each manager's 13F, not the share of Lisata Therapeutics Inc. the manager owns.